We are live on ! Find out more
MXCT icon

MaxCyte

116 hedge funds and large institutions have $303M invested in MaxCyte in 2023 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 48 increasing their positions, 36 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 36

20% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 10

2% more funds holding

Funds holding: 114116 (+2)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0.11% less ownership

Funds ownership: 64.27%64.16% (-0.11%)

38% less capital invested

Capital invested by funds: $489M → $303M (-$186M)

78% less call options, than puts

Call options by funds: $5K | Put options by funds: $23K

Holders
116
Holders Change
+2
Holders Change %
+1.75%
% of All Funds
1.82%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
12
Increased
48
Reduced
36
Closed
10
Calls
$5K
Puts
$23K
Net Calls
-$18K
Net Calls Change
-$16K
Name Holding Trade Value Shares
Change
Change in
Stake
Lazard Asset Management
26
Lazard Asset Management
New York
$2.16M +$15.3K +3,322 +0.7%
RA
27
Royce & Associates
New York
$1.83M +$418K +90,855 +30%
JP Morgan Chase
28
JP Morgan Chase
New York
$1.66M -$86K -18,717 -5%
FAM
29
Fred Alger Management
New York
$1.66M +$1.24M +269,209 +293%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$1.58M +$45.7K +9,940 +3%
Allspring Global Investments
31
Allspring Global Investments
North Carolina
$1.53M -$59.7K -12,990 -4%
RG
32
Rathbones Group
United Kingdom
$1.52M -$97.7K -21,263 -6%
AMH
33
Apollo Management Holdings
New York
$1.41M
N
34
Nuveen
North Carolina
$1.14M
BL
35
Bleichroeder LP
New York
$1.11M
Charles Schwab
36
Charles Schwab
California
$1.09M -$869 -189 -0.1%
CAPTRUST Financial Advisors
37
CAPTRUST Financial Advisors
North Carolina
$957K -$49.7K -10,808 -5%
Swiss National Bank
38
Swiss National Bank
Switzerland
$874K +$166K +36,200 +23%
AIMCA
39
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$812K +$813K +176,812 New
Alyeska Investment Group
40
Alyeska Investment Group
Illinois
$765K +$766K +166,630 New
Goldman Sachs
41
Goldman Sachs
New York
$759K +$139K +30,147 +22%
VA
42
Valmark Advisers
Ohio
$748K +$419K +91,177 +127%
AG
43
Algert Global
California
$735K -$1.13M -245,155 -60%
M&T Bank
44
M&T Bank
New York
$726K +$152K +33,132 +27%
VOYA Investment Management
45
VOYA Investment Management
Georgia
$706K +$172K +37,477 +32%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$604K -$16.7K -3,644 -3%
William Blair & Company
47
William Blair & Company
Illinois
$595K +$55.2K +12,020 +10%
SO
48
STRS Ohio
Ohio
$556K +$21.6K +4,700 +4%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$487K +$48.2K +10,493 +11%
PFM
50
Premier Fund Managers
United Kingdom
$485K -$353K -76,745 -42%

MXCT Hedge Fund Activity: Q2 2023 in Review

116 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in MaxCyte (MXCT) for Q2 2023, worth a combined $303M — down 38% from $489M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new MXCT positions and 10 closed out — a net gain of 2 holders — while 48 added to existing stakes and 36 trimmed.

The largest buyer was Stonepine Capital Management, adding an estimated $5.79M. The largest seller was BAMCO Inc, exiting entirely with an estimated $9.84M sold.

  • 116 institutional investors held MaxCyte (MXCT) as of Q2 2023, up from 114 in Q1 2023.
  • Funds reported $303M of MaxCyte stock for Q2 2023, down 38% quarter-over-quarter.
  • 12 funds opened new MaxCyte positions in Q2 2023 and 10 closed out, a net change of +2 holders.
  • The largest MaxCyte buyer in Q2 2023 was Stonepine Capital Management, an estimated $5.79M added.
  • The largest MaxCyte seller in Q2 2023 was BAMCO Inc, an estimated $9.84M sold.

Based on aggregated 13F filings for Q2 2023.